Literature DB >> 31228539

Influence of inferior petrosal sinus drainage symmetry on detection of adenomas in Cushing's syndrome.

Lukas Andereggen1, Jan Gralla2, Gerhard Schroth2, Pasquale Mordasini2, Robert H Andres1, Hans Rudolf Widmer1, Markus M Luedi3, Frauke Kellner2, Jürgen Beck1, Luigi Mariani4, Christoph Ozdoba2, Emanuel Christ5.   

Abstract

BACKGROUND: Asymmetric inferior petrosal sinuses (IPS) are not infrequently encountered during bilateral IPS sampling. There is little data on whether IPS symmetry influences success in predicting the adenoma side in patients with ACTH-dependent Cushing's syndrome (CS).
OBJECTIVE: To assess the influence of IPS drainage patterns on detection of an adenoma in CS.
METHODS: Retrospective single-center cohort analysis reviewing records of patients with CS and negative MRI findings who subsequently underwent BIPSS.
RESULTS: BIPSS was performed in 38 patients with a mean age of 45±15 years. The overall technical success rate was 97% for bilateral cannulation. Asymmetric IPS were observed in 11 (39%) patients with Cushing's disease (CD). A side-to-side ACTH ratio was not significantly different between patients with symmetric outflow and those with asymmetric outflow at baseline (8.6±2.7 versus 16.4±6.0; P=0.45), but ratios were significantly different after ovine corticotropin-releasing hormone (oCRH) stimulation (6.0±2.5 versus 35.7±22.5; P=0.03). BIPSS correctly predicted the side of the adenoma in 25 (96%) patients with CD. Prediction was better when the venous outflow was symmetric (100%) rather than asymmetric (93%), although the difference was not significant (P=0.42). Remission from CS was achieved in 32 patients (87%), independent of the symmetry of IPS.
CONCLUSIONS: Bearing in mind the sample size of this audit, asymmetric IPS at least do not seem to diminish the accuracy of diagnosis of ACTH-dependent CS, nor do they influence the clinical outcome.
Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Angiography; Cushing's syndrome; Digital subtraction; Venous anatomy

Year:  2019        PMID: 31228539     DOI: 10.1016/j.neurad.2019.05.004

Source DB:  PubMed          Journal:  J Neuroradiol        ISSN: 0150-9861            Impact factor:   3.447


  6 in total

1.  Impact of primary medical or surgical therapy on prolactinoma patients' BMI and metabolic profile over the long-term.

Authors:  Lukas Andereggen; Janine Frey; Robert H Andres; Markus M Luedi; Jan Gralla; Gerrit A Schubert; Jürgen Beck; Luigi Mariani; Emanuel Christ
Journal:  J Clin Transl Endocrinol       Date:  2021-06-17

2.  Persistent bone impairment despite long-term control of hyperprolactinemia and hypogonadism in men and women with prolactinomas.

Authors:  Lukas Andereggen; Janine Frey; Robert H Andres; Markus M Luedi; Hans Rudolf Widmer; Jürgen Beck; Luigi Mariani; Emanuel Christ
Journal:  Sci Rep       Date:  2021-03-04       Impact factor: 4.379

3.  Lateral one-third gland resection in Cushing patients with failed adenoma identification leads to low remission rates: long-term observations from a small, single-center cohort.

Authors:  Lukas Andereggen; Luigi Mariani; Jürgen Beck; Robert H Andres; Jan Gralla; Markus M Luedi; Joachim Weis; Emanuel Christ
Journal:  Acta Neurochir (Wien)       Date:  2021-04-03       Impact factor: 2.816

4.  Machine Learning for Outcome Prediction in First-Line Surgery of Prolactinomas.

Authors:  Markus Huber; Markus M Luedi; Gerrit A Schubert; Christian Musahl; Angelo Tortora; Janine Frey; Jürgen Beck; Luigi Mariani; Emanuel Christ; Lukas Andereggen
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-16       Impact factor: 5.555

5.  Selective resection of cushing microadenoma guided by preoperative hybrid 18-fluoroethyl-L-tyrosine and 11-C-methionine PET/MRI.

Authors:  Sven Berkmann; Michel Roethlisberger; Beat Mueller; Mirjam Christ-Crain; Luigi Mariani; Egbert Nitzsche; Freimut Juengling
Journal:  Pituitary       Date:  2021-06-21       Impact factor: 4.107

6.  First-line surgery in prolactinomas: lessons from a long-term follow-up study in a tertiary referral center.

Authors:  L Andereggen; J Frey; R H Andres; M M Luedi; M El-Koussy; H R Widmer; J Beck; L Mariani; R W Seiler; E Christ
Journal:  J Endocrinol Invest       Date:  2021-04-13       Impact factor: 4.256

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.